ANDA 40216, held by Epic Pharma LLC. Sulfacetamide Sodium.
As of Nov 15, 2026, ANDA 40216 (Sulfacetamide Sodium), held by Epic Pharma LLC, was first approved by FDA on May 25, 1999, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| May 25, 1999 | Original application | Approved |
| Product | Active ingredient | Marketing |
|---|---|---|
| Sulfacetamide Sodium30% ยท solution/drops;ophthalmic | Sulfacetamide Sodium | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
